Finding specific clinical studies on "Sildigra 250 mg" can be challenging as it is a branded formulation of sildenafil citrate, similar to Viagra. Most research and clinical studies are conducted on sildenafil citrate, the active ingredient in Sildigra. General Sildenafil Studies: Extensive clinical studies on sildenafil citrate are available, focusing on its efficacy and safety for treating erectile dysfunction (ED). Sildenafil has been shown to significantly improve erectile function compared to placebo across multiple doses (25 mg, 50 mg, and 100 mg) in various trials (DailyMed) (DailyMed) (DailyMed). Safety and Dosage: The typical maximum recommended dose of sildenafil citrate is 100 mg. Studies indicate that higher doses, such as 200 mg or more, can increase the risk of adverse effects without significantly increasing efficacy. Sildigra 250 mg exceeds these recommended dosages, which raises concerns about its safety profile and potential for adverse effects (DailyMed) (DailyMed). Availability of Studies: Specific studies on branded formulations like Sildigra 250 mg may not be available publicly. Instead, looking at sildenafil citrate's general clinical research can provide insight into its effectiveness and safety. For precise dosage effects and safety concerns, it's best to refer to sildenafil studies and consult healthcare providers for guidance tailored to specific high doses. To delve deeper into clinical studies, websites like PubMed and ClinicalTrials.gov are excellent resources for finding peer-reviewed research articles and ongoing clinical trials related to sildenafil citrate.
Our Mission... “To assist disaster survivors by providing a source for them to come together in time of need, to aid in the listing of events, information and other forms of assistance, and continuing support through the recovery process.”
Share this page with your family and friends.